News and Events




10/2020: UGA Biopharma presents efficient development of stable high titer cell lines at BIO Europe DIGITAL convention 2020
UGA Biopharma GmbH will present its latest high-performance stable CHO cell lines for high titer production of ...read more



09/2020: UGA Biopharma GmbH participates at the virtual CPhI Festival of Pharma 2020
UGA Biopharma GmbH will participate in the virtual CPhI Festival of Pharma 2020 over eleven days in October. The CPhI Festival will take the form of a ...read more



09/2020: FcR affinity chromatography - a new approach to assess glycan profiles
TOSOH Bioscience and UGA Biopharma did cooperate on a project regarding FcR Affinity chromatography. The outcome of this project is described in the ...read more



09/2020: Case study with Evidentic
Evidentic and UGA Biopharma collaborated for a case study which was recently published on the website of Evidentic, “Aliquots: A New Solution to the ...read more



09/2020: New method for EPO purification patented by UGA Biopharma
We have developed a newly patented method for the purification of the evolutionarily conserved hormone Erythropoietin (EPO) and its ...read more



07/2020: UGA Biopharma to debut at digital Bioprocessing Summit Europe
UGA Biopharma GmbH will make its debut at the upcoming annual Bioprocessing Summit Europe conference, now repurposed as a virtual online event in response ...read more



06/2020: UGA Biopharma at the BIO Digital 2020 meeting
We will take part at the annual BIO International Convention USA 2020 for the first time, which was re-branded BIO Digital because of the coronavirus ...read more



04/2020: UGA Biopharma´s high-speed cell line development workflow
The UGA Biopharma GmbH high-speed workflow was established as an improved cell line development workflow that guarantees CHO cell line development on a ...read more



03/2020: COVID-19 statement from UGA Biopharma GmbH
Dear valued customer, partner and friends of UGA Biopharma GmbH, as all of us, we also closely ...read more



03/2020: Meet UGA Biopharma GmbH at BIO-Europe Spring virtual conference
UGA Biopharma GmbH will present its value-added mammalian cell line development services at the upcoming annual BIO-Europe Spring® biotech industry partnering conference, now to be hosted ...read more



11/2019: Meet our CEO at the CPhI in Frankfurt and Bio-Europe in Hamburg
Do not miss the opportunity to meet Dr. Lars Kober, CEO of UGA Biopharma GmbH at the CPhI in Frankfurt from November 5-8, 2019 as well as at ...read more



09/2019: UGA Biopharma presented the benefits of First CHOice® Media
September 18, 2019: Sarah Herrman, head of the Technology Development Group, presented her data at the conference „New and Emerging Technologies – Biotech meets Medicine“ in Potsdam-Golm. ...read more



05/2019: High Ranking Delegation from China
UGA Biopharma welcomed 28 delegates from China. Representatives from chinese health institutes ...read more



05/2019: ESACT Meeting in Copenhagen
On behalf of all UGA team members, we would like to thank all our customers and partners for their valuable and long-standing ...read more



12/2017: Four projects successfully completed in Q4
Four biosimilar development projects were successfully finalized in Q4. Ready-to-use Research Cell Banks are available for out-licensing now! ...read more



11/2017: New CEO
UGA Biopharma announces that Dr. Lars Kober, who was holding Operational Management for many years took over the management of UGA. ...read more



10/2017: Abzena and UGA Biopharma collaborate to treat MS
See our latest press release using that ...read more



09/2017: First CHOice - product promotion in transkript Vol 9
See the current product promotion for our High-Performance Cell Culture Medium First CHOice® published in transkript journal Vol. 9 page 41 via this ...read more



08/2017: Collaboration between Batavia Biosciences and UGA Biopharma
Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing ...read more



07/2017: Meet us at "New & Emerging Technologies" in Potsdam
You can meet us at the congress "New & Emerging ...read more



05/2017: UGA Biopharma presented at Bionnale 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services"...read more



04/2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made ...read more



03/2017: Launch of High Speed Workflow
UGA has launched an improved cell-line-development workflow ("High Speed Workflow"), which guarantees cell line development on a shortened time ...read more




Contact

UGA Biopharma GmbH
Neuendorfstraße 20a
16761 Hennigsdorf
Germany
E-mail:  info@ugabiopharma.com This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49(0)3302 / 2024900